Trump can rein in healthcare costs AND win medical breakthroughs — here’s how
NY POST
Of all the problems bedeviling the American healthcare system, the high cost of pharmaceuticals is one of those most commonly cited by patients.
Polling finds that most Americans think drugs are too expensive, and they’re often right — even if pricey medications beat alternatives like surgery, hospitalization or living with pain.
President Donald Trump has promised to implement healthcare reforms that both increase innovation and improve affordability.
Some see these as contradictory pursuits — but when it comes to pharmaceuticals, both of the president’s goals can be achieved at the same time.
This week the two of us, along with a team of top health and economic experts, launched Most Favored Patients, a working group aimed at developing reforms that will lower drug prices in ways that won’t hinder or delay new drug development.